Trial Profile
A phase I/II trial of EPI-N06
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs EPI N06 (Primary)
- Indications Hyperpigmentation
- Focus Adverse reactions; Therapeutic Use
- Sponsors EpiPharm
- 24 May 2016 New trial record